DE69527624T2 - Antimikrobielle öl-in-wasser-emulsionen - Google Patents

Antimikrobielle öl-in-wasser-emulsionen

Info

Publication number
DE69527624T2
DE69527624T2 DE69527624T DE69527624T DE69527624T2 DE 69527624 T2 DE69527624 T2 DE 69527624T2 DE 69527624 T DE69527624 T DE 69527624T DE 69527624 T DE69527624 T DE 69527624T DE 69527624 T2 DE69527624 T2 DE 69527624T2
Authority
DE
Germany
Prior art keywords
water emulsions
antimicrobial oil
antimicrobial
oil
emulsions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69527624T
Other languages
English (en)
Other versions
DE69527624D1 (de
Inventor
D Craig Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novavax Inc
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/246,868 external-priority patent/US5547677A/en
Priority claimed from US08/322,827 external-priority patent/US5549901A/en
Application filed by Novavax Inc filed Critical Novavax Inc
Application granted granted Critical
Publication of DE69527624D1 publication Critical patent/DE69527624D1/de
Publication of DE69527624T2 publication Critical patent/DE69527624T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
DE69527624T 1994-05-20 1995-05-18 Antimikrobielle öl-in-wasser-emulsionen Expired - Fee Related DE69527624T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/246,868 US5547677A (en) 1994-05-20 1994-05-20 Antimicrobial oil-in-water emulsions
US08/322,827 US5549901A (en) 1994-05-20 1994-10-13 Antimicrobial oil-in-water emulsions
US32973094A 1994-10-26 1994-10-26
PCT/US1995/006236 WO1995031966A1 (en) 1994-05-20 1995-05-18 Antimicrobial oil-in-water emulsions

Publications (2)

Publication Number Publication Date
DE69527624D1 DE69527624D1 (de) 2002-09-05
DE69527624T2 true DE69527624T2 (de) 2003-04-03

Family

ID=27399981

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69527624T Expired - Fee Related DE69527624T2 (de) 1994-05-20 1995-05-18 Antimikrobielle öl-in-wasser-emulsionen
DE69524953T Expired - Fee Related DE69524953T2 (de) 1994-05-20 1995-05-18 Antibakterielle öl-in-wasser-emulsion

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69524953T Expired - Fee Related DE69524953T2 (de) 1994-05-20 1995-05-18 Antibakterielle öl-in-wasser-emulsion

Country Status (10)

Country Link
US (1) US5618840A (de)
EP (2) EP0760650B1 (de)
JP (2) JPH10500687A (de)
CN (2) CN1159158A (de)
AU (2) AU687562B2 (de)
BR (2) BR9507742A (de)
CA (2) CA2190604A1 (de)
DE (2) DE69527624T2 (de)
ES (1) ES2180636T3 (de)
WO (2) WO1995031966A1 (de)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387373B1 (en) * 1993-01-15 2002-05-14 Novavax, Inc. Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
WO1996033697A1 (fr) * 1995-04-24 1996-10-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Formulation auto-emulsionnable formant une emulsion huile dans l'eau
JP2001509779A (ja) * 1995-11-28 2001-07-24 デー． ワイダー，マイケル 抗菌組成物とその使用方法
WO1997021728A1 (en) 1995-12-12 1997-06-19 Karolinska Innovations Ab PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
ZA9610949B (en) * 1996-01-05 1997-08-14 Applied Microbiology Inc Monoglyceride compositions and their use against Helicobacter.
US5981587A (en) * 1996-07-31 1999-11-09 Abbott Laboratories Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
US5958974A (en) * 1996-07-31 1999-09-28 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
US5908862A (en) * 1996-07-31 1999-06-01 Abbot Laboratories Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
CA2257412A1 (en) * 1996-07-31 1998-02-05 Abbott Laboratories Water-miscible esters of monoglycerides having antimicrobial activity
DE19643586A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Gegen Mikroorganismen, Viren, Parasiten und Protozoen wirksame Sterole und Sterolderivate
DE19643587A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sterole und Sterolderivate
US6426078B1 (en) * 1997-03-17 2002-07-30 Roche Vitamins Inc. Oil in water microemulsion
US5753711A (en) * 1997-03-18 1998-05-19 Collagenex Pharmaceuticals, Inc. Method for treatment of H. pylori
FR2771637B1 (fr) * 1997-12-01 2003-10-24 Hutchinson Utilisation d'un halogenure de dialkyldialkylammonium par voie parenterale dans les infections bacteriennes et virales
US6015832A (en) * 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
DE19841794A1 (de) * 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Ceramide und Sphingosine und Derivate) und Mikrobiziden
DE19841795A1 (de) * 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Sterole und Sterolderivate) und Mikrobiziden
DE19841796A1 (de) * 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Kohlenhydrate) und Mikrobiziden
US6506803B1 (en) 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6559189B2 (en) 1999-04-28 2003-05-06 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US8232320B2 (en) 1999-04-28 2012-07-31 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US7767216B2 (en) 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
FR2804868B1 (fr) * 2000-02-15 2003-03-07 Oreal Utilisation de composes permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
FR2804865B1 (fr) * 2000-02-15 2003-11-28 Oreal Utilisation des corps gras particuliers permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
US6423707B1 (en) 2000-08-28 2002-07-23 California Pacific Medical Center Nitroimidazole ester analogues and therapeutic applications
US7314624B2 (en) * 2001-06-05 2008-01-01 The Regents Of The University Of Michigan Nanoemulsion vaccines
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
NZ531492A (en) * 2001-08-28 2007-11-30 Eden Research Plc Treatment and prevention of fungal, bacterial, mycoplasma and phytoplasma infections in plants comprising terpene compounds in true solution
US20030180349A1 (en) * 2001-12-07 2003-09-25 Franklin Lanny U. Respiratory infection prevention and treatment with terpene-containing compositions
EP1476194A4 (de) * 2002-02-19 2005-05-18 Eden Research Plc Zusammensetzungen und verfahren zur konservierung von lebensmitteln
WO2003070286A1 (en) * 2002-02-19 2003-08-28 Eden Research Plc Improvement of indoor air quality and antiseptic composition for use therein
US20040087564A1 (en) * 2002-10-31 2004-05-06 Wright D. Craig Delivery composition and method
AU2003303198A1 (en) 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
US20050014932A1 (en) 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
AU2003304268A1 (en) * 2003-07-03 2005-01-21 Betafarma S.P.A. Antibacterial mouthwash
JP5037939B2 (ja) * 2003-07-07 2012-10-03 ネアーズ エービー マイクロエマルジョンおよび気道疾患を防ぐためのその使用
US8211448B2 (en) 2003-07-07 2012-07-03 Nares Ab Microemulsions and its use for preventing airway diseases
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
FR2861295B1 (fr) * 2003-10-23 2005-12-23 Oreal Emulsion h/e cosmetique ou dermatologique de ph stable
US20050100601A1 (en) * 2003-11-07 2005-05-12 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
JP5189291B2 (ja) * 2003-11-07 2013-04-24 ヴァイラトックス， エルエルシー 塩化セチルピリジニウムの殺ウイルス活性
WO2005047475A2 (en) * 2003-11-11 2005-05-26 Regents Of The University Of Minnesota Regulation of cell membrane-mediated effects
ES2899590T3 (es) 2004-01-23 2022-03-14 Eden Research Plc Métodos de eliminación de nematodos que comprenden la aplicación de un componente terpénico
EP2338332B1 (de) 2004-05-20 2014-02-12 Eden Research Plc Hohles glukan- oder zellenwand-partikel, das eine terpenkomponente verkapselt
US20050260138A1 (en) * 2004-05-21 2005-11-24 Virgil Flanigan Producton and use of a gaseous vapor disinfectant
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
EP1812550A2 (de) * 2004-10-20 2007-08-01 Iogenetics, Llc Biozide
US10918618B2 (en) 2005-03-10 2021-02-16 3M Innovative Properties Company Methods of reducing microbial contamination
ATE511838T1 (de) 2005-03-10 2011-06-15 3M Innovative Properties Co Antimikrobielle zusammensetzungen mit hydroxycarboxylsäureestern
CA2604392A1 (en) * 2005-04-11 2006-10-19 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
WO2008051186A2 (en) * 2005-08-09 2008-05-02 Nanobio Corporation Nanoemulsion containing compositions having ant i -inflammatory activity
US7797337B2 (en) * 2005-09-29 2010-09-14 Scenera Technologies, Llc Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
WO2007063267A1 (en) 2005-11-30 2007-06-07 Eden Research Plc Terpene-containing compositions and methods of making and using them
KR20140103191A (ko) 2005-11-30 2014-08-25 에덴 리서치 피엘씨 티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
US20090321534A1 (en) * 2005-12-02 2009-12-31 Nfd, Llc Aerosol or gaseous decontaminant generator and application thereof
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
US9839685B2 (en) * 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
US20080038295A1 (en) * 2006-04-13 2008-02-14 Regents Of The University Of Michigan Compositions and methods for orthopox virus vaccination
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
WO2008103416A1 (en) * 2007-02-21 2008-08-28 Capps Charles L Synergistic enhancement of calcium propionate
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
JP2011507978A (ja) 2007-12-31 2011-03-10 スリーエム イノベイティブ プロパティズ カンパニー 抗菌剤組成物
US9078864B2 (en) 2008-01-08 2015-07-14 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
AU2009248810B2 (en) * 2008-05-23 2013-12-05 The Regents Of The University Of Michigan Nanoemulsion vaccines
AU2009293595A1 (en) * 2008-05-23 2010-03-25 The Regents Of The University Of Michigan Nanoemulsion adjuvants
CA2738245A1 (en) 2008-09-26 2010-04-01 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
EP2376089B1 (de) 2008-11-17 2018-03-14 The Regents of the University of Michigan Krebsvakzine-zusammensetzungen und anwendungsverfahren dafür
US20110229544A1 (en) * 2008-11-26 2011-09-22 Viroblock S.A. Methods for Inhibiting Gram-Postive Bacteria Using Non-Phospholipid Lipid Vesicules
US8668911B2 (en) 2009-05-14 2014-03-11 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
EP2442827B1 (de) * 2009-06-16 2016-01-06 The Regents of the University of Michigan Nanoemulsionsimpfstoffe
FR2950884B1 (fr) * 2009-10-01 2011-11-11 Oreal Utilisation de derives de vanilline comme conservateur, procede de conservation, composes et composition
EP2563375B1 (de) 2010-04-28 2014-06-25 Alcon Research, Ltd. Pharmazeutische zusammensetzungen mit phosphonium-antimikrobika
US8747534B2 (en) * 2010-12-29 2014-06-10 United States Gypsum Company Antimicrobial size emulsion and gypsum panel made therewith
KR20150008086A (ko) * 2012-04-20 2015-01-21 헨네핀 라이프 사이언스 미생물 감염증의 국소 치료용 조성물
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
CA2963569A1 (en) * 2013-11-04 2015-05-07 Atp Institute Pty Ltd Vasodilator formulation and method of use
ES2924988T3 (es) 2014-10-10 2022-10-13 Univ Michigan Regents Composiciones con nanoemulsiones para prevenir, inhibir o eliminar una enfermedad alérgica e inflamatoria
FR3030279B1 (fr) * 2014-12-17 2019-08-02 Tereos Starch & Sweeteners Belgium Composition antibacterienne contenant un melange isomerique de monoethers ou de monoacetals d'alkyle de monosaccharides
WO2016154010A1 (en) 2015-03-20 2016-09-29 Makidon Paul Immunogenic compositions for use in vaccination against bordetella
WO2017063150A1 (zh) * 2015-10-14 2017-04-20 高雄医学大学 酪梨萃取物、avocadenol B及(2R,4R)-1,2,4-三羟基十七碳-16-炔的用途，以及包含酪梨萃取物的保健食品
US11369578B2 (en) 2018-11-15 2022-06-28 Bluewillow Biologics, Inc. Persistent topical antimicrobial compositions and methods of using the same
FR3093650B1 (fr) 2019-03-11 2022-12-30 Id4Feed Nouveau solvant d’extraction, de solubilisation et/ou de formulation de composés volatiles et non-volatiles d’intérêt en alimentation et santé animale, procédé de préparation et utilisations associées
EP4121026A4 (de) * 2020-03-17 2024-04-10 Bluewillow Biologics Inc Beständige topische antimikrobielle zusammensetzungen und verfahren zur verwendung davon
AU2021254780A1 (en) * 2020-04-16 2022-10-20 Atossa Therapeutics, Inc. Compositions and methods to reduce the infectivity of a virus
FR3110342A1 (fr) 2020-05-21 2021-11-26 Id4Feed Procédé de préparation d’un totum ou d’un filtrat permettant la stabilisation de matière végétale fraîche

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197318A (en) * 1974-07-08 1980-04-08 Johnson & Johnson Potentiated antimicrobial medicaments
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
US4321257A (en) * 1974-07-08 1982-03-23 Johnson & Johnson Potentiated medicaments
AU513753B2 (en) * 1974-07-08 1980-12-18 Johnson & Johnson Antimicrobial composition
US4230702A (en) * 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
US4474748A (en) * 1979-09-26 1984-10-02 Johnson & Johnson Medicaments potentiated with phenyl alkanols
JPS6027646B2 (ja) * 1979-10-31 1985-06-29 花王株式会社 化粧料
US4323551A (en) * 1981-02-19 1982-04-06 The Procter & Gamble Company Mouthwash compositions
US4902720A (en) * 1983-01-10 1990-02-20 Baldone Joseph A Treatment of virus infections with quaternary ammonium compounds
US4997851A (en) * 1987-12-31 1991-03-05 Isaacs Charles E Antiviral and antibacterial activity of fatty acids and monoglycerides
GB8809177D0 (en) * 1988-04-19 1988-05-25 Merrell Doe Pharmaceuticals In Method of preventing aids transmission-resulting from blood transfusions
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
DE69107056T4 (de) * 1990-11-14 1996-06-13 Oreal Amphiphile, nichtionische derivate des glycerins sowie die entsprechenden zwischenprodukte, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
US5176901A (en) * 1991-04-10 1993-01-05 Smithkline Beecham Corporation Dental composition
US5300305A (en) * 1991-09-12 1994-04-05 The Procter & Gamble Company Breath protection microcapsules
CA2082561A1 (en) * 1991-11-12 1993-05-13 Francis J. Leng Antiperspirant materials and compositions
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
ATE218855T1 (de) * 1993-03-22 2002-06-15 Cognis Australia Pty Ltd Wasserdispersible therapeutische carotenoid verbindungen
US5403587A (en) * 1993-04-22 1995-04-04 Eastman Kodak Company Disinfectant and sanitizing compositions based on essential oils
US5534544A (en) * 1994-08-19 1996-07-09 New England Medical Center Hospitals, Inc. Surfactants and emulsifying agents to inhibit Helicobacter

Also Published As

Publication number Publication date
ES2180636T3 (es) 2003-02-16
CN1159158A (zh) 1997-09-10
EP0765151A4 (de) 1998-11-25
US5618840A (en) 1997-04-08
BR9507742A (pt) 1997-10-07
AU687562B2 (en) 1998-02-26
CA2190606A1 (en) 1995-11-30
CN1156404A (zh) 1997-08-06
EP0760650A4 (de) 1998-11-25
WO1995031956A1 (en) 1995-11-30
DE69524953T2 (de) 2002-08-29
DE69527624D1 (de) 2002-09-05
BR9507669A (pt) 1997-10-07
EP0765151A1 (de) 1997-04-02
EP0760650A1 (de) 1997-03-12
AU2593795A (en) 1995-12-18
WO1995031966A1 (en) 1995-11-30
JPH10500686A (ja) 1998-01-20
CN1158069C (zh) 2004-07-21
JPH10500687A (ja) 1998-01-20
EP0760650B1 (de) 2002-07-31
DE69524953D1 (de) 2002-02-14
AU2593695A (en) 1995-12-18
EP0765151B1 (de) 2002-01-09
CA2190604A1 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
DE69527624D1 (de) Antimikrobielle öl-in-wasser-emulsionen
DE59104004D1 (de) Öl-in-wasser-emulsionen.
DE69509464T2 (de) Antimikrobielles Mittel
FI971852A0 (fi) Yhteisvaikutuksellisia biosidiyhdistelmiä
NO954563D0 (no) Vann-i-olje-emulsjonskunststoffgjödselsammensetninger
DE69510254D1 (de) Antimikrobielles Mittel
DE69832477D1 (de) Fett-emulsionen
DE59509592D1 (de) Wasser-in-öl-emulsionen
NO971140D0 (no) Insekticider
ATA200295A (de) Wasser-in-öl-emulsionen
BR7500101U (pt) Tesoura
ATE413917T1 (de) Schichtenbildungsresistente emulsionen
DE69622947T2 (de) Verbesserte Öl-in-Wasser Emulsionen
NO955053D0 (no) Emulgeringsmiddel
ZA959426B (en) Antimicrobial oil-in-water emulsions
DE69419332T2 (de) Öl-in-Wasser Emulsion
KR960020619U (ko) 가위
AT68U3 (de) Doppelschereinschub doppelschereinschub
KR960018679U (ko) 입간판
ITAQ940004A0 (it) Emulsione anticalvizie
ZA95940B (en) Oil-in-water emulsions
ZA959427B (en) Antibacterial oil-in-water emulsions
KR960008201U (ko) 오일펜스
DE59507939D1 (de) Homogenisierungsvorrichtung
DE59510768D1 (de) Lormetazepamhaltige Öl-in-Wasser-Emulsion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee